ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,258,000 | -27.9% | 938,900 | -13.0% | 0.90% | -31.2% |
| Q3 2014 | $4,520,000 | -11.1% | 1,078,600 | +24.3% | 1.31% | -22.3% |
| Q2 2014 | $5,085,000 | -48.5% | 867,700 | -44.7% | 1.68% | -48.8% |
| Q1 2014 | $9,877,000 | -14.8% | 1,567,700 | -20.9% | 3.29% | -32.1% |
| Q4 2013 | $11,591,000 | +71.6% | 1,981,400 | +54.6% | 4.85% | +43.9% |
| Q3 2013 | $6,753,000 | -31.6% | 1,281,400 | 0.0% | 3.37% | -20.0% |
| Q2 2013 | $9,867,000 | – | 1,281,400 | – | 4.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |